Regulation of hematopoietic stem cell differentiation
Regulation of hematopoietic stem cell differentiation
批准号:
8761288
负责人:
Iannis Aifantis
金额:
$14.01万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-11-27 至 2015-05-31
关键词:
Acute Lymphocytic LeukemiaAddressAdultAffectAgreementAllelesAnimal ModelBindingBiochemical GeneticsBiological ProcessBlood CellsCell Cycle RegulationCell divisionCell physiologyCellsChromatinDataDominant-Negative MutationEquilibriumGene ExpressionGene Expression ProfileGene TargetingGeneticGenomeGenomicsGrantHealthHematopoiesisHematopoiesis InductionHematopoieticHematopoietic NeoplasmsHematopoietic stem cellsImmune systemKnock-in MouseKnock-outKnockout MiceLeadLifeMaintenanceMalignant NeoplasmsMediatingMissense MutationModelingMutationOncogenesOncogenicOrganismPatientsPhenotypePhysiologicalPlayPoint MutationPopulationPost-Translational Protein ProcessingProliferatingProteinsProto-Oncogene Proteins c-mycProtocols documentationRegulationRoleSignal TransductionStem cellsSystemTestingTimeTissuesTumor Suppressor ProteinsUbiquitinationc-myc Genesembryonic stem cellfetalgenome-wideleukemialoss of functionmouse modelnotch proteinnovelprogenitorself-renewalstem cell differentiationubiquitin-protein ligase
中文摘要
描述(申请人提供):所有成熟的血细胞都来自一种罕见的特殊群体,即造血干细胞(HSCs),它们大多处于静止状态。HSCs的细胞分裂导致它们的增殖和逐渐分化为越来越受血统限制的成熟血细胞,以及维持一小部分不分化的HSCs,而是在生物体的整个生命中进行造血。由于HSC功能的重要性,阐明控制HSC自我更新和分化之间平衡的信号是一项至关重要的任务。有趣的是,几项研究表明,生理性造血和诱导恶性血液病(白血病)之间存在密切的平衡,这是由能够转化HSC和祖细胞的异常信号控制的。与这一观点一致,我们最近发现E3泛素连接酶Fbw7在急性淋巴细胞白血病(ALL)中是一个重要的肿瘤抑制因子。Fbw7失活突变在很大一部分患者中被发现,并由于包括Notch1和c-Myc在内的几个重要癌基因的异常稳定性而诱导转化。我们利用一种新的条件性基因敲除小鼠模型研究了Fbw7在HSC功能中的作用。我们发现,Fbw7的缺失以一种细胞自主的方式特异性地、快速地影响HSC间隔室。Fbw7-/-HSC表现出维持静止的缺陷,导致自我更新受损和竞争性再生能力的严重丧失。此外,对Fbw7-/-HSC的全基因组转录组研究表明,Fbw7调节与静止的、自我更新的HSC表型相关的全球转录“签名”。在这一应用中,我们:a)确定Fbw7靶向的HSC特异性蛋白底物,在HSC分化和功能中发挥重要作用;b)通过研究Fbw7在胚胎干细胞功能中的作用,解决其在干细胞自我更新中的普遍功能;c)研究所有Fbw7错义突变在造血和HSC自我更新中的作用。
英文摘要
DESCRIPTION (provided by applicant): All mature blood cells arise from a rare and specialized population, the hematopoietic stem cells (HSCs), which exist mostly in a quiescent state. Cell division of HSCs results in both their proliferation and progressive differentiation into increasingly lineage-restricted mature blood cells, as well as maintenance of a small pool of HSCs that do not differentiate, but rather carry out hematopoiesis throughout the life of an organism. Due to the significance of HSC function, the elucidation of the signals that govern the balance between HSC self-renewal and differentiation is a paramount task. Interestingly, several studies have suggested an intimate balance between physiological hematopoiesis and induction of hematopoietic malignancy (leukemia) controlled by aberrant signaling that is able to transform HSC and progenitor cells. In agreement with this notion, we have recently identified the E3 ubiquitin ligase Fbw7 as an important tumor suppressor in acute lymphocytic leukemia (ALL). Fbw7 inactivating mutations are found in a large fraction of ALL patients and induce transformation due to the aberrant stability of several important oncogenes, including Notch1 and c-Myc. We have addressed the role of Fbw7 in HSC function using a novel conditional knock-out mouse model. We have found that deletion of Fbw7 specifically and rapidly affected the HSC compartment in a cell-autonomous manner. Fbw7-/- HSCs showed defective maintenance of quiescence, leading to impaired self-renewal and a severe loss of competitive repopulating capacity. Furthermore, genome-wide transcriptome studies of Fbw7-/- HSC indicated that Fbw7 regulates a global transcriptional "signature" associated with the quiescent, self-renewing HSC phenotype. In this application we: a) Identify HSC-specific protein substrates targeted by Fbw7 and playing important roles in HSC differentiation and function, b) address the universal function of Fbw7 in stem cell self-renewal by studying its role in embryonic stem cell function and c) study the effects of ALL Fbw7 missense mutations in hematopoiesis and HSC self- renewal.
期刊论文(21)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
The controversial role of the Hedgehog pathway in normal and malignant hematopoiesis.
刺猬途径在正常和恶性造血中有争议的作用。
DOI:
10.1038/leu.2011.143
发表时间:
2011-11
期刊:
Leukemia
影响因子:
11.4
作者:
[]
通讯作者:
DOI:
10.1002/emmm.201302909
发表时间:
2014-01
期刊:
EMBO MOLECULAR MEDICINE
影响因子:
11.1
作者:
[Rustighi, Alessandra, Zannini, Alessandro, Tiberi, Luca, Sommaggio, Roberta, Piazza, Silvano, Sorrentino, Giovanni, Nuzzo, Simona, Tuscano, Antonella, Eterno, Vincenzo, Benvenuti, Federica, Santarpia, Libero, Aifantis, Iannis, Rosato, Antonio, Bicciato, Silvio, Zambelli, Alberto, Del Sal, Giannino]
通讯作者:
Del Sal, Giannino
DOI:
10.1016/j.stem.2012.09.011
发表时间:
2012-12-07
期刊:
CELL STEM CELL
影响因子:
23.9
作者:
[Buckley, Shannon M., Aranda-Orgilles, Beatriz, Strikoudis, Alexandros, Apostolou, Effie, Loizou, Evangelia, Moran-Crusio, Kelly, Farnsworth, Charles L., Koller, Antonius A., Dasgupta, Ramanuj, Silva, Jeffrey C., Stadtfeld, Matthias, Hochedlinger, Konrad, Chen, Emily I., Aifantis, Iannis]
通讯作者:
Aifantis, Iannis
DOI:
10.1016/j.it.2012.01.009
发表时间:
2012-07
期刊:
Trends in immunology
影响因子:
16.8
作者:
[Moran-Crusio K, Reavie LB, Aifantis I]
通讯作者:
Aifantis I
Energy addiction and lymphocyte differentiation: a new role for the liver kinase B1 kinase.
能量成瘾和淋巴细胞分化:肝激酶 B1 激酶的新作用。
DOI:
10.1002/eji.200940206
发表时间:
2010
期刊:
European journal of immunology
影响因子:
5.4
作者:
[Aifantis,Iannis, Sawai,Catherine]
通讯作者:
Sawai,Catherine
共 15 条
The role of inflammation in the regulation of immune response in acute myeloid leukemia
-
批准号:10729281
-
项目类别:
-
资助金额:$57.03万
-
财政年份:2023
-
负责人:Iannis Aifantis
-
依托单位:
Dissecting innate immune signaling in pre-leukemia evolution
-
批准号:10584536
-
项目类别:
-
资助金额:$62.55万
-
财政年份:2022
-
负责人:Iannis Aifantis
-
依托单位:
Dissecting innate immune signaling in pre-leukemia evolution
-
批准号:10462192
-
项目类别:
-
资助金额:$65.3万
-
财政年份:2022
-
负责人:Iannis Aifantis
-
依托单位:
mRNA stability and its impact on hematopoiesis and acute leukemia
-
批准号:10339742
-
项目类别:
-
资助金额:$54.01万
-
财政年份:2022
-
负责人:Iannis Aifantis
-
依托单位:
mRNA stability and its impact on hematopoiesis and acute leukemia
-
批准号:10543125
-
项目类别:
-
资助金额:$52.93万
-
财政年份:2022
-
负责人:Iannis Aifantis
-
依托单位:
Regulation of emergency hematopoiesis by the ubiquitin-proteasome system
-
批准号:10279596
-
项目类别:
-
资助金额:$65.32万
-
财政年份:2021
-
负责人:Iannis Aifantis
-
依托单位:
Regulation of emergency hematopoiesis by the ubiquitin-proteasome system
-
批准号:10634676
-
项目类别:
-
资助金额:$62.79万
-
财政年份:2021
-
负责人:Iannis Aifantis
-
依托单位:
Project 3: Oncogenic triggers and their influence on 3D chromosomal architecture
-
批准号:10652283
-
项目类别:
-
资助金额:$41.18万
-
财政年份:2019
-
负责人:Iannis Aifantis
-
依托单位:
Mechanisms of enhancer regulation in leukemia
-
批准号:10545714
-
项目类别:
-
资助金额:$49.24万
-
财政年份:2019
-
负责人:Iannis Aifantis
-
依托单位:
Developmental Research Program
-
批准号:10434092
-
项目类别:
-
资助金额:$7.88万
-
财政年份:2019
-
负责人:Iannis Aifantis
-
依托单位:
Mechanisms of enhancer regulation in leukemia
-
批准号:10321638
-
项目类别:
-
资助金额:$49.24万
-
财政年份:2019
-
负责人:Iannis Aifantis
-
依托单位:
Project 3: Oncogenic triggers and their influence on 3D chromosomal architecture
-
批准号:10402273
-
项目类别:
-
资助金额:$32.45万
-
财政年份:2019
-
负责人:Iannis Aifantis
-
依托单位:
Project 3: Oncogenic triggers and their influence on 3D chromosomal architecture
-
批准号:10153723
-
项目类别:
-
资助金额:$41.78万
-
财政年份:2019
-
负责人:Iannis Aifantis
-
依托单位:
Developmental Research Program
-
批准号:10200706
-
项目类别:
-
资助金额:$7.88万
-
财政年份:2019
-
负责人:Iannis Aifantis
-
依托单位:
The cohesin complex as a tumor suppressor in myeloid leukemia
-
批准号:9922231
-
项目类别:
-
资助金额:$49.69万
-
财政年份:2017
-
负责人:Iannis Aifantis
-
依托单位:
Post-translational control of cancer cell stress response and metastasis
-
批准号:9302310
-
项目类别:
-
资助金额:$45.95万
-
财政年份:2016
-
负责人:Iannis Aifantis
-
依托单位:
Post-translational control of cancer cell stress response and metastasis
-
批准号:9920691
-
项目类别:
-
资助金额:$45.95万
-
财政年份:2016
-
负责人:Iannis Aifantis
-
依托单位:
Post-translational control of cancer cell stress response and metastasis
-
批准号:9189485
-
项目类别:
-
资助金额:$44.54万
-
财政年份:2016
-
负责人:Iannis Aifantis
-
依托单位:
Mapping cancer micro-environments for acute leukemia
-
批准号:9185681
-
项目类别:
-
资助金额:$46.36万
-
财政年份:2016
-
负责人:Iannis Aifantis
-
依托单位:
Long non-coding RNAs in hematopoiesis and blood malignancy
-
批准号:8875983
-
项目类别:
-
资助金额:$45.75万
-
财政年份:2015
-
负责人:Iannis Aifantis
-
依托单位:
海外基金